Similarly, transwell assay and CCK8 assay results indicated that the knockdown of SPRY2 in liver cancer cells relieved the inhibitory effects of anti-miR-27a-3p on cell proliferation and migration (Supplementary Figures S5C, D). This evidence concerns the gene SPRY2 and liver cancer.